Tim Opler gives an update on biotech in China (starting on page 47), highlighting the rapid change.
Biopharma Market Update
Stifel
Tim Opler
Research
106 Pages
Key Takeaways
Sentiment: Higher energy level and better mood overall in the Chinese biotech community – triggered by the recovery of the biotechs on the Hong Kong Stock Exchange.
Government Support: The Chinese government has made it clear that it will do what it can to support its biotech sector, although no dramatic pronouncements have been made.
Buyers Market: There remain many more sellers than buyers in the market and the scale of the available pipeline is enormous.